Steven J. Mento - Nov 7, 2022 Form 4 Insider Report for Histogen Inc. (HSTO)

Role
Interim President and CEO, Director
Signature
/s/ Susan A. Knudson as attorney-in-fact for Steven J. Mento, Ph.D.
Stock symbol
HSTO
Transactions as of
Nov 7, 2022
Transactions value $
-$2,854,750
Form type
4
Date filed
11/9/2022, 03:29 PM
Previous filing
Feb 25, 2022
Next filing
Mar 14, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HSTO Restricted Stock Units Disposed to Issuer -$2.85M -11.4K -100% $250.00 0 Nov 7, 2022 Common Stock 11.4K Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 On November 7, 2022, the Issuer and the Reporting Person agreed to cancel the restricted stock unit award prior to the vesting of such award in exchange for cash.
F3 Effective June 2, 2022, the Issuer effected a 1-for-20 reverse stock split of the Company's issued and outstanding common stock, par value $0.0001 per share.
F4 The restricted stock unit award was cancelled as of November 7, 2022 prior to any vesting or exercisability thereof.